Sight Sciences (SGHT) Cash from Financing Activities (2020 - 2026)
Sight Sciences' quarterly Cash from Financing Activities came in at $88000.0 in Q1 2026, up 450.0% year-on-year from $16000.0 in Q1 2025, and down 93.04% quarter-over-quarter from $1.3 million in Q4 2025.
Sight Sciences has reported Cash from Financing Activities for 7 years, with the latest figure at $88000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 450.0% year-over-year to $88000.0; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 68.54% YoY), and the FY2025 full-year result was $1.8 million, down 63.92% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $88000.0, down from $1.3 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $5.4 million in Q4 2024, with the low at -$942000.0 in Q1 2024.
- Average Cash from Financing Activities over 5 years is $540882.4, with a median of $158000.0 recorded in 2022.
- Peak annual rise in Cash from Financing Activities reached 1333.24% in 2024, while the deepest fall reached 503.85% in 2024.
- Tracing SGHT's Cash from Financing Activities over 5 years: stood at $812000.0 in 2022, then tumbled by 53.69% to $376000.0 in 2023, then jumped by 1333.24% to $5.4 million in 2024, then sank by 76.53% to $1.3 million in 2025, then plunged by 93.04% to $88000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $88000.0 (Q1 2026), $1.3 million (Q4 2025), and $25000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Sight Sciences | 247.60 Mn | 162.64 Mn | 16.98 Mn | 88,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 5.39 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 441,000.00 |
| Jun 30, 2024 | 441,000.00 |
| Mar 31, 2024 | -942,000.00 |
| Mar 31, 2024 | -942,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 766,000.00 |
| Jun 30, 2023 | 766,000.00 |
| Mar 31, 2023 | -156,000.00 |
| Mar 31, 2023 | -156,000.00 |
| Dec 31, 2022 | 812,000.00 |
| Dec 31, 2022 | 812,000.00 |
| Sep 30, 2022 | 186,000.00 |
| Sep 30, 2022 | 186,000.00 |
| Jun 30, 2022 | 158,000.00 |
| Jun 30, 2022 | 158,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 91,000.00 |
| Dec 31, 2021 | 91,000.00 |
| Sep 30, 2021 | 252.70 Mn |
| Sep 30, 2021 | 252.70 Mn |
| Jun 30, 2021 | -54,000.00 |
| Jun 30, 2021 | -54,000.00 |
| Mar 31, 2021 | -210,000.00 |
| Mar 31, 2021 | -210,000.00 |
| Dec 31, 2020 | 43.52 Mn |
| Dec 31, 2020 | 43.52 Mn |
| Sep 30, 2020 | -170,000.00 |
| Sep 30, 2020 | -170,000.00 |